the next generation of anti-infective

DEINOVE is active in the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the global challenge of antibiotic resistance, a major health threat:

  • Building a portfolio of first-in-class antibiotic candidates, which places it among the major players in the field, by bringing together a global network of expertise (Morphochem, bioMérieux, Naicons, Medpace),
  • Preparing the entry into Phase II of a first antibiotic candidate targeting severe gastrointestinal infections caused by Clostridioides difficile.
  • Systematically exploring a targeted biological diversity to supply its portfolio with new leads. This program called AGIR - Antibiotics against Resistant Infectious Germs - is supported by Bpifrance and conducted in collaboration with the Institut Charles Viollette of Lille (University of Lille I).


Discover what DEINOVE is doing in the search for new antibiotics.

Antibiotics discovery platform